Cerebrospinal fluid analysis in clinical diagnosis

Journal of Clinical Pathology

Volumn 50, Issue 3, 1997, Pages 187-192

  Olukoga, A O ^a   Bolodeoku, J ^b   Donaldson, D ^c  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c EAST SURREY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CEREBROSPINAL FLUID; HISTORY; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030980112     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.3.187     Document Type: Review

References (67)

1. Clarke E, O'Malley CD. The ventricular system and CSF. In: The human brain and spinal cord. 1st ed. Berkeley, Los Angeles: University of California Press, 1968:708-55.
2. Torack RM. Historical aspects of normal and abnormal brain fluids: I. Cerebrospinal fluid. Arch Neurol 1982;39: 197-201.
3. Viets H. Domenico Cotugno: His description of the cerebrospinal fluid. Bull Inst Hist Med 1935;3:701-38.
4. Magendie F. Treatise on a liquid that is found within the cranium and the spinal canal of man and mammals. J Physiol Exp Pathol 1825;5:27-37.
5. Magendie F. Further notes on the cerebrospinal fluid. J Physiol Exp Pathol 1827;7:5-27,66-82.
6. Faivre J. Recherches sur la structure du conarium et des plexus choroides chez l'homme et les animaux. Gaz Med Paris 1854;9:555.
7. Von Luschka H. Die Adergeflechte des menschlichen Gehirns. Leipzig, G Reimer, 1855. cited by Torack RM. Historical aspects of normal and abnormal brain fluids: I. Cerebrospinal fluid. Arch Neurol 1982;39:197-201.
8. Von Luschka H. Die Adergeflechte des menschlichen Gehirns. Leipzig, G Reimer, 1855. cited by Torack RM. Historical aspects of normal and abnormal brain fluids: I. Cerebrospinal fluid. Arch Neurol 1982;39:197-201.
9. Key A, Retzius G. Studien in der Anatomie des Nervensystems und des Bindgewebes. Stockholm: Samson and Wallin, 1876.
10. Quinke HJ. Die Lumbalpunction des Hydrocephalus. Berl Klin Wochenschr 1891;28:929-65.
11. Mestrezat W. Le liquide céphalo-rachidien normal et pathologique, valeur clinique de l'examen chimique. Thèse No.17, 1911.
12. Lichtheim L. Re: The proposal of Quincke to withdraw cerebrospinal fluid by lumbar puncture in cases of brain disease. Dtsch Med Wochenschr 1893;19:1234.
13. Bulloch W. The history of bacteriology. 1st ed. London: Oxford University Press, 1938.
14. Von Wassermann A, Plaut F. Ueber das Vorhandensein Syphilitischer Antistoffe in der Cerebrospinal flüssigkeit von Paralytikern. Dtsch Med Wochenschr 1906;32:1769-72.
15. Castellani A. On the discovery of a species of trypanosoma in the cerebrospinal fluid of cases of sleeping sickness. Proc R Soc 1903;71:501-8.
16. Marks V, Marrack D. Tumour cells in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1960;23:194-201.
17. Millian G, Chiray. Méningite à pneumocoques. Xanthochromie du liquide céphalo-rachidien. Bull Soc Anat Paris 1902;4:550-2.
18. Froin G. Inflammations meningées avec réactions chromatique, fibrineuse et cytologique du liquid céphalorachidien. Gaz Hôp Paris 1903;76:1005-6.
19. Nonne M. Ueber das Vorkommen von starker phase-1-reaction bei fehlender lymphocytose bei 6 Fällen von Rückenmarkstumor. Deutscht: Ztschr f Nervenh, Leipz 1910; 40:161-7.
20. Robinson FH, Miller BN. On differentiation of coloured cerebrospinal fluids. Am J Med Sci 1936;191:538-42.
21. Barrows LJ, Hunter FT, Banker BQ. The nature and clinical significance of pigments in the cerebrospinal fluid. Brain 1955;78:59-81.
22. Lange C. Die Ausflockung Kolloidalen Goldes durch Zerebrospinalflussigheit bei luetischen Affektionen des zentranervensystems. Z Chemother 1912;1:44-78.
23. Lange C, Harris AH. The significance of the pH in the colloidal gold reaction. J Lab Clin Med 1944;29:970.
24. Kabat EA, Moore DH, Landow H. An electrophoretical study of the protein components in cerebrospinal fluid and their relationships to the serum proteins. J Clin Invest 1942;21:571-7.
25. Kabat EA, Glusman M, Knaub V. Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Am J Med 1948;4:653-62.
26. Goodwin GM, Shelley HJ. The sugar content of the cerebrospinal fluid and its relation to the blood sugar. Arch Intern Med 1925;35:242-58.
27. Marks V. True glucose content of lumbar and ventricular cerebrospinal fluid. J Clin Pathol 1960;13:82-4.
28. Greenwald KA, Speicher CE, Evers W, Henry JB. Glucose content in cerebrospinal fluid: A comparison with glucose levels in serum as determined by copper reduction and hexokinase methods. Am J Cllin Path 1973;59:518-20.
29. Peters T Jr, Biamonte GT, Doumas BT. Protein (total protein) in serum, urine and cerebrospinal fluid; albumin in serum. In: Faulkner WR, Meites S, eds. Selected methods of clinical chemistry. Washington, DC: American Association for Clinical Chemistry, 1982.
30. Daughday WH, Lowry OH, Rosebrough NJ, Fields WS. Determination of cerebrospinal fluid protein with the Folin phenolic reagent. J Lab Clin Med 1952;39:663.
31. Nishimura K. The lactic acid content of blood and spinal fluid. Proc Soc Exp Biol Med 1924;22:322-4.
32. Davson H. Blood-brain and blood-CSF barriers. In: Physiology of the cerebrospinal fluid. 1st ed. London: Churchill Ltd, 1967:296-8.
33. Haerer AF, Tourtelotte W, Richard KA, Gustafson GM, Byran ER. A study of the blood-CSF-brain barrier in multiple sclerosis. I. Blood-CSF barrier to NaBr. Neurology 1964;14:345-54.
34. Delpech B, Lichtblau E. Etude quantitative des immunoglobulines G et de l'albumine du liquide cephalorachidien. Clin Chim Acta 1972;37:15-23.
35. Frick E. Immunophoretische Untersuchungen am Liquor cerebrospinalis. Klin Wochenschr 1959;37:645-51.
36. Link H. Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid: chemical and immunological characterisation with special reference to multiple sclerosis. Acta Neurol Scand 1967;43(Suppl 28):1-136.
37. Delmotte P. Resultats comparatifs de l'electrophorese en agar et de l'examen par electrofocalisation des gammaglobulines du liquide cephalorachidien. Acta Neurol Belg 1972; 72:226-34.
38. Porter KG, Sinnamon DG, Gillies RR. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis. Lancet 1977;i: 1262.
39. Thompson EJ, Keir G. Laboratory investigation of cerebrospinal fluid proteins. Ann Clin Biochem 1990;27:425-35.
40. Felgenhauer K, Schliep G, Rapic N. Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system. J Neurol Sci 1976;30:113-28.
41. Schliep G, Felgenhauer K. The alpha-2-macroglobulin level in CSF: a parameter for the condition of the blood-CSF barrier. J Neurol 1974;207:171-81.
42. Keir G, Thompson EJ. Proteins as parameters in the discrimination between different blood-CSF barriers. J Neurol Sci 1986;75:245-53.
43. Thompson EJ. The CSF proteins: A biochemical approach. Amsterdam: Elsevier, 1988.
44. Bernheimer H, Birkmayer W, Hornykiewicz O. Homovanillic acid in the cerebrospinal fluid in Parkinson's syndrome and other diseases of the CNS. Wien Klin Wochenschr 1966; 23:417-19.
45. Wood JH. Neurobiology of cerebrospinal fluid. I. New York: Plenum, 1980.
46. Wrohlewski F, Decker B, Wroblewski R. Activity of lactate dehydrogenase in spinal fluid. Am J Clin Pathol 1957;28: 269-71.
47. Chatterley S, Sun T, Lien Y. Diagnostic value of lactate dehydrogenase isoenzymes in cerebrospinal fluid. J Clin Lab Anal 1991;5:168-74.
48. Bach F, Bach FW, Pedersen AG, Larsen PM, Dombernowsky P. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. Eur J Cancer Oncol 1989;25:1703-9.
49. Lampl Y, Paniri Y, Eshel Y, Sarova-Pinchas I. Alkaline phosphatase level in CSF in various brain tumours and pulmonary carcinomatous meningitis. J Neurooncol 1990;9:35-40.
50. BenGershom E, Briggeman-Mol GJ, de Zegher F. Cerebrospinal fluid C-reactive protein in meningitis: diagnostic value and pathophysiology. Eur J Paediatr 1986;145:246-9.
51. Hourani BT, Hamlin EM, Reynolds TB. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch Intern Med 1971;127:1033-6.
52. Lopez-Cortes LF, Cruz-Ruiz M, Gomez-Mateos J, Jimenez-Hernandez D, Palomino J, Jimenez E. Measurement of levels of tumour necrosis factor-alpha and interleukin-1-beta in the CSF of patients with meningitis of different aetiologies: utility in the differential diagnosis. Clin Infect Dis 1993;16:534-9.
53. Maimone D, Gregory S, Arnason BG, Reder AT. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 1991;32:67-74.
54. McArthur JC, Nance-Sproson TE, Griffin DE, Hoover D, Selnes OA, Miller EN, et al. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Neurology 1992;42:1707-12.
55. Griffin DE, McArthur JC, Cornblath DR. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 1991;41:69-74.
56. Whitaker JN, Lisak RP, Bashir RM, Fitch OH, Sever JM, Krance R, et al. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol 1980;7:58-64.
57. Liuzzi GM, Mastroianni CM, Vullo V, Jirillo E, Delia S, Riccio P. Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex. J Neuroimmunol 1992;36:251-4.
58. van Gool WA, Bolhuis PA. Cerebrospinal fluid markers of Alzheimer's disease. J Am Geriatr Soc 1991;39:1025-39.
59. Farlow M, Ghetti B, Benson MD, Farrow JS, van Nostrand WE, Wagner SL. Low cerebrospinal fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease. Lancet 1992;340:453-4.
60. Adachi N. Beta-2-microglobulin levels in the cerebrospinal fluid: their value as a disease marker. A review of the recent literature. Eur Neurol 1991;31:181-5.
61. Beelen NAA, Twijnstra A, van de Pol M, Menheere PPCA. Neuron-specific enolase in cerebrospinal fluid of patients with metastatic and non-metastatic neurological disease. Eur J Cancer 1993;29A:193-5.
62. Watson AM, Scott GM. Clinical utility of biochemical analysis of cerebrospinal fluid. Clin Chem 1995;41:343-60.
63. Kam-Hausen S, Fryden A, Link H. B and T lymphocytes in cerebrospinal fluid and blood in multiple sclerosis, optic neuritis and mumps meningitis. Acta Neurol Scand 1978;58:95-103.
64. Davies SF, Gormus BJ, Yarchoan R, Kaplan ME. Cryptococcal meningitis with false-positive cytology in the cerebrospinal fluid: use of T-cell rosetting to exclude meningeal lymphoma. JAMA 1978;239:2369-78.
65. Goodson JD, Strauss GM. Diagnosis of lymphomatous leptomeningitis by cerebrospinal fluid lymphocyte cell surface markers. Am J Med 1979;66:1057-9.
66. Dayan AD, Stokes MI. Rapid diagnosis of encephalitis by immunofluorescent examination of cerebrospinal fluid cells. Lancet 1973;i:177-9.
67. Balows A, Hausler Jr. WJ, Herrmann KL, Isenberg HD, Shadomy HJ, editors. Manual of clinical microbiology: Diagnostic technologies in clinical microbiolagy. 5th ed. Washington, DC: American Society of Microbiology, 1991:119-27.